Back to search

University of Glasgow

The role of insulin sensitising agents in polycystic ovary syndrome

Abstract

dc:description.abstract

Polycystic Ovary Syndrome (PCOS) is a common disorder of chronically abnormal ovarian function and hyperandrogenism whose clinical effects include oligomenorrhoea and hirsutism. It has been determined that the principal underlying defect is hyperinsulinaemia secondary to insulin resistance. Use of insulin sensitising agents in women with PCOS is becoming increasingly widespread. Trials with metformin, one such agent, enthusiastically report a wide range of benefits in metabolic, reproductive and clinical measures. We have shown that metformin treatment of women with polycystic ovary syndrome has the following effects; o It may be more effective than Dianette in the treatment of hirsutism. o It is effective in reducing weight and improves lipid profiles in obese women with oligomenorrhea or a raised free androgen index. o It reduces serum mullerian inhibiting substance in the circulation after protracted treatment (> 4months). o It has effects upon adrenal androgen biosynthesis manifested by a reduction in circulating basal concentrations of 170HP.

Degree

thesis:*
Level dc:type.qualificationlevel
MD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
2005

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Harborne, Lyndal Ruth

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Harborne, Lyndal Ruth. The role of insulin sensitising agents in polycystic ovary syndrome. MD thesis, University of Glasgow, 2005.